Rib-X Pharmaceuticals Inc. Lands $25,000,000 Series D Round

  • Feed Type
  • Date
    2/4/2009
  • Company Name
    Rib-X Pharmaceuticals Inc.
  • Mailing Address
    300 George Street New Haven, CT 06511-6663
  • Company Description
    Rib-X Pharmaceuticals is a product-driven small molecule drug discovery and development company focused on the structure-based design of new classes of antibiotics. The company’s underlying drug discovery engine capitalizes on its proprietary high-resolution crystal structure of the 50S subunit of the ribosome, which performs an essential role in the fundamental process of protein synthesis.
  • Website
    http://www.rib-x.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $25,000,000
  • Transaction Round
    Series D
  • Proceeds Purposes
    Proceeds purposes were not disclosed.
  • M&A Terms
  • Venture Investor
    Warburg Pincus
  • Venture Investor
    ABS Ventures
  • Venture Investor
    Axiom Venture Partners
  • Venture Investor
    EuclidSR Partners
  • Venture Investor
    MedImmune Ventures
  • Venture Investor
    Oxford Bioscience Partners
  • Venture Investor
    SR One
  • Venture Investor
    Undisclosed

By posting a comment, you agree to our terms and conditions.